- This blog is a discussion about our system of public and private health care.
-

Blogroll
About Me
Alison Bass is a Pulitzer Prize nominee and author of Side Effects: A Prosecutor, a Whistleblower and a Bestselling Antidepressant on Trial, which won the NASW Science in Society Award. She was a longtime medical and science writer for The Boston Globe and has also written for The Miami Herald, Psychology Today and MIT's Technology Review, among other publications. A series she wrote for The Boston Globe on psychiatry was nominated for a Pulitzer Prize and she has received many other journalism awards. In 2007, she won a prestigious Alicia Patterson Fellowship to write Side Effects. Bass teaches journalism at Mount Holyoke College and Brandeis University.Blog Archive
- June 2013 (1)
- February 2013 (1)
- November 2012 (1)
- October 2012 (1)
- September 2012 (4)
- August 2012 (1)
- July 2012 (2)
- June 2012 (3)
- May 2012 (3)
- April 2012 (2)
- February 2012 (2)
- January 2012 (3)
- December 2011 (3)
- November 2011 (3)
- October 2011 (2)
- September 2011 (4)
- August 2011 (3)
- July 2011 (3)
- June 2011 (4)
- May 2011 (4)
- April 2011 (3)
- March 2011 (3)
- February 2011 (3)
- January 2011 (4)
- December 2010 (3)
- November 2010 (2)
- September 2010 (2)
- July 2010 (1)
- May 2010 (1)
- April 2010 (1)
- March 2010 (3)
- February 2010 (3)
- January 2010 (4)
- December 2009 (4)
- November 2009 (5)
- October 2009 (4)
- September 2009 (6)
- August 2009 (7)
- July 2009 (4)
- June 2009 (5)
- May 2009 (4)
- April 2009 (7)
- March 2009 (4)
- February 2009 (3)
- January 2009 (4)
- December 2008 (4)
- November 2008 (3)
- October 2008 (4)
- September 2008 (5)
- August 2008 (2)
- July 2008 (6)
- June 2008 (5)
- May 2008 (1)
- April 2008 (1)
Monthly Archives: February 2009
DOJ lawsuit against Forest Labs: a bold new attack on a longstanding practice
Share The New York Times today reported that the Justice Department has sued Forest Labs for defrauding the government of millions of dollars by illegally marketing Celexa and Lexapro, its two blockbuster antidepressants. The fraud complaint is based on allegations … Continue reading
Posted in Uncategorized
7 Comments
Attacks on stimulus funding to compare medical treatment: Sound familiar?
Share In a long-overdue step toward health care reform, the massive economic stimulus bill that the Obama administration approved on Tuesday includes $1.1 billion to compare the effectiveness of drugs, medical devices, surgery and other medical procedures. The money will … Continue reading
Posted in Uncategorized
4 Comments
GlaxoSmithKline takes a $400 million hit
Share The health blog of The Wall Street Journal was the first to report Jan. 29 that GlaxoSmithKline is taking a $400 million hit related to federal and state probes into the drug giant’s research and marketing shenanigans. Glaxo announced … Continue reading
Posted in Uncategorized
Leave a comment